Shenouda Maged — SEC insider filings
SEC reporting owner CIK 1658369. 23 insider filings on record with FilingPulse; latest filed 2026-09-11.
Transaction summary — filings shown
Covers all 23 filings on record, filed 2021-01-11 to 2026-09-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 13 legs across 6 filings — 997,772 shares, $2,364,675 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 18 legs across 7 filings — 36,000 shares, $1,257,012 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 28.
- Largest priced transaction: purchase of 500,000 shares @ $2.20 ($1,100,000) in RELMADA THERAPEUTICS, INC., filed 2025-11-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | Chief Financial Officer | 23 | 13 legs · 997,772 sh · $2,364,675 | 18 legs · 36,000 sh · $1,257,012 | 28 |
Insider filings — Shenouda Maged
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-11 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Purchase (P): 120,200 @ $4.20 · Purchase (P): 79,800 @ $4.25 | EDGAR |
| 2025-12-16 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Purchase (P): 11,665 @ $4.12 · Grant/award (A): 828,000 (derivative) @ $0 | EDGAR |
| 2025-11-06 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Purchase (P): 500,000 @ $2.20 | EDGAR |
| 2025-06-30 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2025-05-20 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Purchase (P): 50,000 @ $0.44 · Purchase (P): 90,000 @ $0.49 · Purchase (P): 60,000 @ $0.52 | EDGAR |
| 2024-09-11 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Purchase (P): 8,194 @ $2.55 · Purchase (P): 21,118 @ $2.73 · Purchase (P): 24,120 @ $2.95 | EDGAR |
| 2024-05-29 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Grant/award (A): 54,624 (derivative) @ $0 · Other (J): 54,624 (derivative) @ $0 | EDGAR |
| 2024-01-31 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Purchase (P): 10,800 @ $3.65 · Purchase (P): 15,000 @ $3.89 · Purchase (P): 6,875 @ $4.06 | EDGAR |
| 2023-12-19 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Grant/award (A): 82,090 (derivative) @ $0 | EDGAR |
| 2023-05-30 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Grant/award (A): 317,643 (derivative) @ $0 | EDGAR |
| 2022-12-20 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Grant/award (A): 194,917 (derivative) @ $0 | EDGAR |
| 2022-12-20 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Other (J): 200,000 (derivative) | EDGAR |
| 2022-05-26 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Grant/award (A): 295,211 (derivative) @ $0 · Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2021-12-21 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Grant/award (A): 227,518 (derivative) @ $0 | EDGAR |
| 2021-03-10 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Option exercise (M): 10,000 @ $3.24 · Sale (S): 100 @ $35 · Sale (S): 5,727 @ $35.42 · Sale (S): 1,800 @ $36.02 · Sale (S): 2,373 @ $35.11 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2021-02-26 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Option exercise (M): 3,000 @ $3.24 · Sale (S): 1,600 @ $33.74 · Sale (S): 1,400 @ $34.67 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2021-02-16 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Option exercise (M): 1,428 @ $3.24 · Sale (S): 1,428 @ $35.39 · Option exercise (M): 1,428 (derivative) @ $0 | EDGAR |
| 2021-02-10 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Option exercise (M): 11,372 @ $3.24 · Sale (S): 3,603 @ $35.04 · Sale (S): 5,359 @ $35.24 · Sale (S): 2,410 @ $35.20 · Option exercise (M): 11,372 (derivative) @ $0 | EDGAR |
| 2021-02-04 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Option exercise (M): 3,200 @ $3.24 · Sale (S): 3,100 @ $35.04 · Sale (S): 100 @ $35 · Option exercise (M): 3,200 (derivative) @ $0 | EDGAR |
| 2021-01-29 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Option exercise (M): 3,000 @ $3.24 · Sale (S): 1,800 @ $31.59 · Sale (S): 1,200 @ $32.43 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2021-01-27 | 4/A | RELMADA THERAPEUTICS, INC. (RLMD) | Option exercise (M): 4,000 @ $3.24 | EDGAR |
| 2021-01-26 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Option exercise (M): 4,000 @ $324 · Sale (S): 1,704 @ $35.41 · Sale (S): 409 @ $36.15 · Sale (S): 1,280 @ $35.27 · Sale (S): 607 @ $35.16 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2021-01-11 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Grant/award (A): 127,500 (derivative) @ $0 · Grant/award (A): 127,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-01-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1658369 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs